RE:RE:CCThe "company....there is revenue incoming that was produced in Q3 but could not be realized due to it being invoiced" statement leaves too much to speculation. After 6 weeks of Q3 and claimed revenue of $1 million, the last 6 weeks show slightly North of another $400,000. If this number after invoicing comes to at least $1 million revenue for the last 6 weeks of Q3, that is what everyone at least expects. Leading up to Q3 a run up was expected, instead the reverse happened. Let's hope the numbers jive as they should and the broader markets gain confidence in SZ's ability to play with the big boys in the pharmaceutical industry. Good luck all. VM.